跳至主要内容
临床试验/CTRI/2025/01/079620
CTRI/2025/01/079620尚未招募3 期

Efficacy and safety of Siddha regimen for management of mild to moderate iron deficiency anaemia amongst reproductive age-group women as compared to iron folic acid supplements: An open labelled, multicentric randomized controlled trial

National Institue of Siddha2 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2025年2月10日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
170
试验地点
2
主要终点
The average change in Hb level at timepoint one two and 3 months as compared to baseline

研究概览

简要总结

Anemia/Paandu is one of the important illnesses, which cause a severe disease burden among Indians. The World Health Organization (WHO) has estimated that globally, 1.62 billion people are anemic and it was especially prevalent among rural areas of India. According to WHO global statistics, 40% of pregnant women, and 42% of children under the age of five are anaemic. It alters immune mechanisms and also associated with increased morbidity rates. The economic and social growth of a nation is impacted by anaemia, as it is attributed to delayed cognitive and motor development in children and reduced work capacity in adults (WHO, 2022).The WHO has recognised iron deficiency anaemia (IDA) as the most common nutritional deficiency in the world, with 30% of the population being affected with this condition. Although the most common causes of IDA are gastrointestinal bleeding and menstruation in women, decreased dietary iron and decreased iron absorption are also culpable causes. Patients with IDA should be treated with the aim of replenishing iron stores and returning the haemoglobin to a normal level.

In India, seven out of every 10 children from 6 to 59 months are anaemic. Anemia is a major public health concern in India. According to National Health Family Survey 5 (2019-21), 57.2% women of reproductive age group (15 to 49 years) suffer from anemia in India . To reduce the burden of anemia in the country, the Government of India launched Anemia Mukt Bharat Programme in 2018 with the objective of reducing the prevalence of anemia by 3 percentage points per year among children, adolescents, and women in the reproductive age group (15–49 years), between the year 2018 and 2022 . A targeted prevalence reduction of anemia in women of the reproductive age group was set from 57% (2016) to 35% (2022) under this programme [4]. However, the prevalence of anemia has been found to be almost the same. The major issue with IFA supplements is poor compliance due to forgetfulness and intolerable GI side effects Iron deficiency and iron load both can cause oxidative stress which in turn causes intestinal mucosal damage due to inflammation. Thus, iron absorption is affected in most of the anaemic patients which may reduce the effect of oral iron supplements and may cause gastrointestinal problems . The addition of Vitamin C to IFA is helpful in enhancing the absorption of iron by keeping it in a reduced ferrous form. However, it does not address the issue of gastrointestinal side effects. Although the conventional treatment for iron deficiency anaemia involves taking iron supplements like ferrous sulphate or elemental iron, adherence to the medicine is challenging due to variety of adverse side effects like metallic taste, epigastric discomfort, nausea, diarrhoea, constipation, etc. The adverse effects of iron supplements can be reduced by taking medications with food. However, doing so might decrease the absorption of iron. Therefore, there is a need to search for innovative drugs that have better therapeutic value and lesser side effects (Nguyen and Tadi, 2022).

In Siddha system of medicine anaemia condition may be compared with the word Paandu literally means pallor. In this clinicalcondition the conjunctiva, tongue, nail bed turns into pallor and it is having been named as Paandu Noi. Syn:Velluppu Noi, Venmai Noi. There are many herbo mineral medicines which are found effective in alleviating iron deficiency anaemia which contains Punica granataVitis vinifera, Nigella Sativa, Smilax china, processed elemental iron. This study  aims to compare the efficacy of Siddha regimen containing traditional oleation by medicated oil Arakkuthylam[9], deworming by NaakkupoochiKudineer followed byBavana Kadukkai ,Aya BhringarajaPaanitham, constituted for anaemia with Standard of Care. Likewise Aya bhringarajaPaanitham contains iron in its elemental iron in combination with herbal medicines which is indicated for Paandu Noi as per Siddha literature, this is also an effective haematinic which can be used as first line of treatment for anaemia even in pediatric population, this drug has undergone repeated dose 28 day oral toxicity studies and revealed no observed adverse effect level (NOAEL) in animals as per Vijaya Kumar et al. Thus the safety of the drug in human usage was ensured.

Need foratrial

Despite of wide promotion of IFA amongst beneficiaries, the burden of anemia remains the same which suggests the need for additional measures to improve nutrition, compliance, and/or additional use of alternative systems of medicine that can address the issue of assimilation of iron and its GI side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 49.00 Year(s)(—)
性别
Female

入选标准

  • Women of reproductive age group from 18 to 49 years with mild to moderate iron deficiency anemia Serum ferritin lesser than 30 mcg per dL Should consent to receive any type of intervention before randomization Not participating in any other research study.

排除标准

  • Pregnant and lactating women Women planning for pregnancy in the next 3 months at the time of screening Known case of anaemia due to other causes including thyroid dysfunction and anaemia of chronic diseases Known diabetics on anti-diabetic drugs Those who have HbA1C greater than 7 Those who are already consuming IFA more than 14 days Known allergy to iron and ingredients of Siddha regimen Patient with known chronic kidney and liver disease Any other condition in advice of treating doctor that is putting participant on risk due to study participation.

结局指标

主要结局

The average change in Hb level at timepoint one two and 3 months as compared to baseline

时间窗: Baseline 15th day end of one two and 3 months

Average change in Serum iron Total Iron binding capacity Ferritin Transferrin saturation levels at baseline and 3 months

时间窗: Baseline 15th day end of one two and 3 months

Average RBC MCV MCH and MCHC levels at timepoint 1 2 and 3 months as compared to baseline

时间窗: Baseline 15th day end of one two and 3 months

Association of Mukkutram categories at baseline with Hb improvement

时间窗: Baseline 15th day end of one two and 3 months

次要结局

  • Proportions of treatment emergent adverse events(Baseline, 15days, 30days, 60days, 90days)

研究者

发起方
National Institue of Siddha
申办方类型
Other [Autonomous body, National Institute of Siddha]
责任方
Principal Investigator
主要研究者

Dr P Shanmugapriya

National Institute of Siddha

研究点 (2)

Loading locations...

相似试验